| domain | key evidence/finding | suggested ontology identifiers |
|---|---|---|
| Disease identifiers | Raine syndrome is an ultra-rare osteosclerotic skeletal dysplasia caused by biallelic **FAM20C** loss-of-function; legacy disease identifiers include **OMIM 259775** and the historical descriptor “congenital sclerosing osteomalacia with cerebral calcification” (**OMIM 259660**). Open Targets links **FAM20C** to **MONDO_0009821 lethal osteosclerotic bone dysplasia**; mapping between MONDO labels and Raine syndrome nomenclature should be curated carefully. Prevalence reported as **<1/1,000,000**. (pqac-00000000, pqac-00000003, pqac-00000006) | MONDO_0009821; OMIM:259775; OMIM:259660; MeSH/Orphanet/ICD term-only suggestions |
| Gene / molecular basis | Causal gene: **FAM20C** (Golgi-associated secretory pathway kinase). Human disease mechanism is predominantly **germline autosomal recessive loss of function**. Reported pathogenic classes include whole-gene deletions, microdeletions, missense, nonsense, splice-site, and frameshift/truncating variants; 2024 review context summarized **42 variants** total (**22 lethal, 20 nonlethal**). Residual kinase activity is thought to correlate with nonlethal survival, but genotype-phenotype prediction remains imperfect. (pqac-00000003, pqac-00000005, pqac-00000008) | HGNC:FAM20C term-only suggestion; SO:missense_variant / nonsense_variant / splice_donor_variant / frameshift_variant / deletion term-only suggestions |
| Inheritance / population | Inheritance is **autosomal recessive**. Published review-level aggregation identified **70 total cases** through 2021 (**41 lethal, 29 nonlethal**), indicating extreme rarity and likely ascertainment bias. No robust carrier-frequency or incidence estimate was identified in the retrieved evidence. (pqac-00000003, pqac-00000006, pqac-00000011) | HP:Autosomal recessive inheritance (term-only suggestion); epidemiology ontology term-only suggestions |
| Core phenotype (skeletal / craniofacial) | Core recurrent manifestations include **generalized osteosclerosis**, periosteal bone formation, flat facial profile, **hypoplastic nose**, **midface hypoplasia**, **prominent eyes/exophthalmos**, choanal atresia/stenosis, and severe respiratory compromise in lethal neonatal disease. Nonlethal cases may evolve from osteosclerosis toward osteomalacia/rickets-like features with variable craniofacial persistence. (pqac-00000002, pqac-00000003, pqac-00000006, pqac-00000011) | HPO term-only suggestions: osteosclerosis; periosteal bone thickening; flat facies; hypoplastic nose; midface retrusion; exophthalmos; choanal atresia/choanal stenosis; respiratory insufficiency |
| Core phenotype (neurologic / imaging) | **Intracranial/intracerebral calcifications** are a hallmark; neurological features can include **developmental delay, intellectual disability, seizures, structural brain defects**, and in prenatal imaging an echogenic brain or enlarged choroid plexus. 2023 mouse work further supports intracranial calcification as a disease-relevant feature. (pqac-00000002, pqac-00000006, pqac-00000010, pqac-00000011) | HPO term-only suggestions: intracranial calcification; cerebral calcification; developmental delay; intellectual disability; seizures; abnormality of the choroid plexus |
| Core phenotype (oral / dental / gingival) | Nonlethal disease frequently includes **hypoplastic amelogenesis imperfecta**, dentin defects, gingival hyperplasia/overgrowth, fibrosis, and ectopic gingival calcifications. The 2024 proteomics study documented fibrosis and pathological gingival calcifications in two unrelated patients with distinct nonlethal variants. (pqac-00000003, pqac-00000008, pqac-00000009) | HPO term-only suggestions: amelogenesis imperfecta; abnormal dentin morphology; gingival overgrowth; gingival fibrosis; ectopic calcification |
| Laboratory abnormalities | Nonlethal Raine syndrome is repeatedly associated with **hypophosphatemia** and disturbed phosphatemia regulation; mechanistic literature links FAM20C deficiency to abnormal **FGF23** handling and phosphate wasting. Exact laboratory ranges were not available in retrieved context. (pqac-00000002, pqac-00000004, pqac-00000007, pqac-00000009) | HPO term-only suggestions: hypophosphatemia; increased circulating FGF23; renal phosphate wasting |
| Mechanism / pathophysiology | FAM20C is a **Golgi kinase** that phosphorylates secreted phosphoproteins, especially proteins involved in biomineralization. Disease mechanism: FAM20C loss impairs phosphorylation/localization/activity of secreted substrates, disrupting **SIBLING proteins**, **FGF23** regulation, extracellular matrix organization, and mineralization in bone/teeth; 2024 work additionally implicates **TGFβ/SMAD** and **YAP/TAZ** signaling in gingival fibrosis. (pqac-00000002, pqac-00000003, pqac-00000008, pqac-00000009) | GO term-only suggestions: protein phosphorylation; biomineral tissue development; extracellular matrix organization; regulation of phosphate ion homeostasis; TGF-beta receptor signaling pathway; SMAD protein signal transduction; Hippo signaling/YAP-TAZ-related transcription |
| Anatomy affected | Primary structures: **craniofacial skeleton**, long bones, teeth, gingiva, and brain/intracranial tissues; secondary involvement includes airways/choanae and lungs via respiratory compromise/pulmonary hypoplasia in lethal neonatal disease. (pqac-00000002, pqac-00000003, pqac-00000006, pqac-00000009) | UBERON term-only suggestions: craniofacial skeleton; long bone; tooth; gingiva; brain; choroid plexus; choana; lung |
| Cell / tissue types | Disease-relevant cell populations inferred from human and model evidence include **osteoblast-lineage cells**, **odontoblasts**, **ameloblasts**, **gingival fibroblasts**, and likely brain-resident cells affected by abnormal phosphoproteome/mineralization. The 2024 human study specifically analyzed **primary gingival fibroblasts**. (pqac-00000008, pqac-00000009, pqac-00000010) | CL term-only suggestions: osteoblast; odontoblast; ameloblast; fibroblast; gingival fibroblast; neuron term-only suggestion |
| Subcellular localization | Normal FAM20C is **Golgi-localized** within the secretory pathway; disease-associated dysfunction includes altered localization and loss of effective Golgi association. In gingival fibroblasts from affected individuals, 2024 data showed increased **ER colocalization** and reduced cis-Golgi association. (pqac-00000008, pqac-00000002) | GO Cellular Component term-only suggestions: Golgi apparatus; Golgi lumen; endoplasmic reticulum; extracellular region |
| Diagnostics | Diagnosis is based on clinical-radiologic suspicion plus **molecular confirmation of biallelic FAM20C variants**. Useful findings include prenatal ultrasound recognition of characteristic facies and intracranial calcification, postnatal skeletal imaging showing osteosclerosis, brain imaging for calcifications, and biochemical assessment of phosphate/FGF23 axis where survival permits. No standardized disease-specific diagnostic criteria were identified in the retrieved evidence. (pqac-00000006, pqac-00000011) | MAXO term-only suggestions: molecular genetic testing; exome sequencing; genome sequencing; targeted gene panel; prenatal ultrasound; skeletal radiography; cranial CT/MRI; serum phosphate measurement |
| Treatment / supportive care | No approved disease-modifying therapy specific to Raine syndrome was identified. Management is **supportive and multidisciplinary**: neonatal airway/respiratory support in lethal presentations; management of hypophosphatemia/rickets-like disease in survivors; dental and periodontal care for amelogenesis imperfecta/gingival disease. Experimental mouse data suggest **high-phosphate diet** can improve skeletal development, but this is preclinical and not an established human therapy. (pqac-00000007, pqac-00000009) | MAXO term-only suggestions: respiratory support; phosphate supplementation; active vitamin D analogue therapy term-only suggestion; dental surveillance; periodontal management; nutritional management; multidisciplinary care |
| Prognosis / course | Prognosis is bimodal: classic lethal disease often causes death in the **first weeks of life**, largely due to **pulmonary hypoplasia/respiratory failure**; nonlethal disease shows **variable expressivity** with childhood-to-adult survival and chronic skeletal, neurologic, hearing/vision, and dental morbidity. Long-term survival statistics were not available. (pqac-00000003, pqac-00000006, pqac-00000008, pqac-00000011) | HPO term-only suggestions: pulmonary hypoplasia; respiratory failure; variable expressivity |
| Model organisms / experimental systems | Mouse **Fam20c-deficient** models recapitulate key features including abnormal mineralization, hypophosphatemic rickets/osteomalacia-like changes, dental defects, and **intracranial calcification** (2023). Human mechanistic evidence also includes 2024 **gingival proteomics**, primary fibroblast studies, siRNA knockdown, and prior in vitro kinase assays. (pqac-00000002, pqac-00000007, pqac-00000008, pqac-00000009) | NCBITaxon term-only suggestion: Mus musculus; GO/CL term-only suggestions as above |
| Evidence limitations | Much evidence comes from **case reports, small families, reviews, mouse studies, and one 2024 two-patient omics study**. Many exact ontology IDs, laboratory ranges, penetrance estimates, founder effects, and standardized treatment outcomes were not available in retrieved context; phenotype frequencies are incompletely quantified and likely affected by publication bias. (pqac-00000003, pqac-00000006, pqac-00000008, pqac-00000011) | Evidence Ontology term-only suggestions: case report; review; animal model; in vitro experiment; proteomics study |


*Table: This compact table summarizes the main knowledge-base elements for Raine syndrome, including identifiers, core phenotypes, mechanisms, anatomy, diagnostics, management, and evidence gaps. It is useful as a structured seed for ontology mapping and curation.*